Galera Therapeutics, Inc.
GRTX
$0.09
$0.00-4.61%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 1,021.79% | 886.25% | 54.18% | 54.72% | 64.66% |
| Total Depreciation and Amortization | -- | -- | -100.00% | -97.93% | -95.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2,054.84% | -1,831.31% | -45.75% | 4.13% | -34.79% |
| Change in Net Operating Assets | 136.05% | 68.75% | 78.08% | 70.03% | 71.01% |
| Cash from Operations | 51.15% | 50.19% | 65.57% | 72.18% | 74.74% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 87,400.00% | 87,400.00% | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 7,708.70% | 7,708.70% | -101.26% | -100.32% | -100.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -71.43% | -- | -37.01% | -54.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -71.43% | 1,331.90% | 50.26% | -23.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.51% | 80.80% | 75.07% | 59.43% | 44.75% |